Treatment of Multiple Myeloma: ASCO Living Guideline, Version 2026.1.3

This guideline has been updated. This ASCO Living Guideline is reviewed on an eight-week cycle. Please see the online dynamic version for the latest updates. Living guidelines are developed for selected topic areas with rapidly evolving evidence that drives frequent change in recommended clinical practice. Living guidelines are updated on a regular schedule by a standing expert panel that systematically reviews the health literature on a continuous basis, as described in the ASCO Guidelines Methodology Manual . ASCO Living Guidelines follow the ASCO Conflict of Interest Policy Implementation for Clinical Practice Guidelines . Living Guidelines and updates are not intended to substitute for independent professional judgment of the treating clinician and do not account for individual variation among patients. See appendix for disclaimers and other important information (Appendix I and Appendix II). Updates are published regularly and can be found on the ASCO Publications website .

Authors

Institutions

Publication Details

Journal
Journal of Clinical Oncology
Published
2026-09-30
DOI
https://doi.org/10.1200/jco-26-02399
Primary Topic
Multiple Myeloma Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Treatment of Multiple Myeloma: ASCO Living Guideline, Version 2026.1.3

Rahul Kumar Banerjee, Shaji Kunnathu Kumar, Hans J. Messersmith, Samer Al Hadidi et al.
Journal of Clinical Oncology
Multiple Myeloma Research and Treatments
article

Treatment of Multiple Myeloma: ASCO Living Guideline, Version 2026.1.3

Rahul Kumar Banerjee, Shaji Kunnathu Kumar, Hans J. Messersmith, Samer Al Hadidi, Benjamin Avi Derman, Lisa K. Hicks, Latha Subramanian, Saurabh Zanwar, Mohammad S. Ebraheem, Rahul Seth, Matthew C. Cheung
article en

Abstract

This guideline has been updated. This ASCO Living Guideline is reviewed on an eight-week cycle. Please see the online dynamic version for the latest updates. Living guidelines are developed for selected topic areas with rapidly evolving evidence that drives frequent change in recommended clinical practice. Living guidelines are updated on a regular schedule by a standing expert panel that systematically reviews the health literature on a continuous basis, as described in the ASCO Guidelines Methodology Manual . ASCO Living Guidelines follow the ASCO Conflict of Interest Policy Implementation for Clinical Practice Guidelines . Living Guidelines and updates are not intended to substitute for independent professional judgment of the treating clinician and do not account for individual variation among patients. See appendix for disclaimers and other important information (Appendix I and Appendix II). Updates are published regularly and can be found on the ASCO Publications website .

Journal of Clinical Oncology
St. Michael's Hospital (CA), American Society of Clinical Oncology (US), Sunnybrook Health Science Centre (CA), Mayo Clinic (US), University of Alaska Anchorage (US), SUNY Upstate Medical University (US), Kuwait Cancer Control Center (KW), University of Chicago (US), Fred Hutch Cancer Center (US), United Way of Anchorage (US), The University of Texas Southwestern Medical Center (US)
Openalex Percentile: Top 11%
Multiple Myeloma Research and Treatments
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.